CCAIM
Novel AI to transform healthcare
Today the University of Cambridge announces a five-year agreement with AstraZeneca and GSK to fund the Cambridge Centre for AI in Medicine (CCAIM). For the 5-year duration, AstraZeneca and GSK …
The question of which patient should receive a life-saving donor organ is one of the thorniest in medicine. Donor organs are a scarce resource, each one as unique as the …
Four members of the 10-strong CCAIM faculty have clocked up a total of 18 papers accepted at NeurIPS 2020 – one of the most prestigious international conferences for AI and …
World-leading expertise in healthcare-focused machine learning combined with the world’s largest, high-quality cancer data collection service could lead to a quantum leap in personalised medicine. (This article, featuring the work …
